What is Evestra?
Evestra, Inc. is a privately held biopharmaceutical company dedicated to advancing women's health and oncology through the development of novel products. The company's pipeline encompasses pre-clinical and clinical-stage assets targeting conditions such as fertility control, endometriosis, hormone replacement therapy, and overactive bladder. With a strategic base in Texas, Evestra leverages over a decade of expertise to address critical unmet needs in women's healthcare, aiming to improve global health outcomes with its next-generation technologies.
How much funding has Evestra raised?
Evestra has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Evestra?
The substantial late-stage funding Evestra has attracted signals a pivotal phase for the company, likely geared towards accelerating clinical trials, expanding its commercialization efforts, and potentially pursuing strategic partnerships. This capital infusion is expected to fuel the advancement of its promising pipeline, particularly in the competitive women's health and oncology sectors. Evestra's focus on addressing underserved areas positions it for significant growth and impact in the biopharmaceutical landscape.
See full Evestra company page
